HighTower Advisors, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2013$41,000
-8.9%
12,858
-13.2%
0.00%0.0%
Q2 2013$45,00014,8080.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,255,691$7,173,0005.84%
NEA Management Company, LLC 2,086,755$6,636,0000.26%
TOURADJI CAPITAL MANAGEMENT, LP 10,000$32,0000.10%
Loeb Offshore Management LP 101,000$321,0000.10%
BVF INC/IL 150,000$477,0000.08%
ABNER HERRMAN & BROCK LLC 20,000$64,0000.04%
SABBY MANAGEMENT, LLC 173,500$552,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 67,000$213,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 52,000$165,0000.00%
PANAGORA ASSET MANAGEMENT INC 96,858$307,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders